Interferon-α (IFN-α) 
Introduction

Interferon-α (IFN-α) has been widely used for the treatment of chronic viral hepatitis. However, several reports have suggested that IFN-α may cause certain autoimmune diseases including thyroiditis, systemic lupus erythematosus, hematologic disorders, insulin-dependent diabetes mellitus, and dermatologic diseases (1). Certain neurological disorders have also been reported such as myasthenia gravis, axonal neuropathy, and central nervous system (CNS) demyelination (2, 3). We report a patient with chronic inflammatory demyelinating polyneuropathy (CIDP) associated with the IFN-α treatment which was taken for hepatitis C virus (HCV) infection. Intravenous immunoglobulin therapy im-
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,
of polyneuropathy was triggered by the initiation of IFN-α treatment. In this case, polyneuropathy appeared to be associated with demyelination and satisfied the electrophysiologic criteria for the diagnosis of CIDP proposed by the American Academy of Neurology (4). The prompt response to IVIg also suggests the patient's neuropathy was caused by an immune-mediation. These findings suggest that the disease of this patient was CIDP triggered by IFN-α. To date, there have been relatively few case reports of autoimmune neuropathy induced by IFN-α; two cases of CIDP and two cases of motor neuropathy were found (5-8). In cases of CIDP, paresthesia was first noted several months after the initiation of IFN-α treatment, and worsened despite the withdrawal of IFN-α. Neither anti-ganglioside antibodies nor cryoglobulins were detected in these cases
. To our knowledge, this is the first report to demonstrate the beneficial therapeutic effects of IVIg against CIDP triggered by IFN-α. IFN-α is type I interferon, and a leukocyte-derived cytokine that is used for the treatment of chronic HCV infection. Immunomodulatory properties, including activation of natural killer cells and cytotoxic T lymphocytes, upregulation of class I and II major histocompatibility complexes, and terminal differentiation of dendritic cells (DCs), are assumed to be responsible for the antiviral effect (9, 10). On the other hand, it was reported that IFN-α may initiate autoimmune disorders such as SLE (1-3). The mechanism of these actions is not yet fully understood; however, it is suggested that IFN-matured myeloid DCs activate autoreactive T cells, and these cells, together with plasma cytoid DCs, help expansion of autoreactive B cells (11). IFN-matured DCs also activate cytotoxic CD8 + T cells, possibly increasing apoptotic cell availability (11).
The mechanism of CIDP is not fully understood; however, an important role for DCs in the pathogenesis of inflammatory neuropathies is also suggested by the recent study, which showed that NOD mice deficient in CD86 costimulation develop a spontaneous CIDP-like disease associated with DC and T cell infiltration into peripheral nerve system tissue (12) . In CIDP, DCs are probably initially recruited to inflamed spinal nerve roots and adjacent meninges to take up released antigens (13 (14) . There have been several reports indicating an association between HCV infection and neuropathy (15, 16) . The neuropathy is sensory or sensorymotor with a symmetrical or asymmetrical pattern, probably associated with mononeuritis multiplex (17) . Neurophysiological and neuropathological findings are compatible with axonal neuropathy with secondary demyelination (17) . In very rare cases, the HCV-cryoglobulinemia-associated neuropathy may be demyelinative (18) . However, the onset of our patient's neuropathy was clearly related to the administration of IFN-α, occurred 
